Courageous Discourse™ with Dr. Peter McCullough & John Leake

Share this post

VIZIR (Viral Infection treatment with oral ZInc: a Randomized controlled trial in COVID-19)

petermcculloughmd.substack.com

Discover more from Courageous Discourse™ with Dr. Peter McCullough & John Leake

Advancement of clinical science, protection of personal autonomy, liberty, and constitutional rights.
Over 92,000 subscribers
Continue reading
Sign in

VIZIR (Viral Infection treatment with oral ZInc: a Randomized controlled trial in COVID-19)

2022 Omicron Era Trial Found Twice Daily Zinc Reduced Need for ICU or Death

Peter McCullough, MD
Apr 10, 2023
348
Share this post

VIZIR (Viral Infection treatment with oral ZInc: a Randomized controlled trial in COVID-19)

petermcculloughmd.substack.com
75
Share
Article voiceover
1×
0:00
-4:12
Audio playback is not supported on your browser. Please upgrade.

By Peter A. McCullough, MD, MPH

It is a shame that blue ribbon US academic medical centers failed to lead on randomized trials in the treatment of acute COVID-19. Even simple interventions were ignored by NIH and university medical centers, thus we waited for trials from elsewhere which have confirmed some of our early impressions of promising drugs in the McCullough, Zelenko, Raoult, and FLCCC Protocols for the early ambulatory treatment of COVID-19.

Ben Abdallah et al from Tunisia recently published the VIZIR trial (viral infection treatment with oral zinc: a randomized controlled trial in COVID-19) which randomized a spectrum of acute COVID-19 patients to zinc 25 mg po bid versus placebo. Zinc has been known for decades to be an inhibitor of RNA-dependent polymerase. There was a 42% reduction in the primary composite of needing ICU admission or death. It is noteworthy, that the two most common companion drugs for zinc, hydroxychloroquine and ivermectin where not mentioned anywhere in the paper. Additionally, while the authors indicate they diligently recorded information about COVID-19 vaccination, none of the data are given in the paper.

Ben Abdallah S, Mhalla Y, Trabelsi I, Sekma A, Youssef R, Bel Haj Ali K, Ben Soltane H, Yacoubi H, Msolli MA, Stambouli N, Beltaief K, Grissa MH, Khrouf M, Mezgar Z, Loussaief C, Bouida W, Razgallah R, Hezbri K, Belguith A, Belkacem N, Dridi Z, Boubaker H, Boukef R, Nouira S. Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial. Clin Infect Dis. 2023 Jan 13;76(2):185-191. doi: 10.1093/cid/ciac807. Erratum in: Clin Infect Dis. 2023 Feb 03;: PMID: 36367144.

We are left with justification for the continued use of zinc. Patients were fortunate to have doctors and hospitals throughout the pandemic who followed multidrug protocols that included zinc among several other nutraceuticals. I wonder how many hospitalized patients in the world never received a single tablet of zinc? I am pleased that 50 mg elemental zinc (220 mg of zinc sulfate) has been in the McCullough Protocol since August 7, 2020.

If you find “Courageous Discourse” enjoyable and useful to your endeavors, please subscribe as a paying or founder member to support our efforts in helping you engage in these discussions with family, friends, and your extended circles.

Ben Abdallah S, Mhalla Y, Trabelsi I, Sekma A, Youssef R, Bel Haj Ali K, Ben Soltane H, Yacoubi H, Msolli MA, Stambouli N, Beltaief K, Grissa MH, Khrouf M, Mezgar Z, Loussaief C, Bouida W, Razgallah R, Hezbri K, Belguith A, Belkacem N, Dridi Z, Boubaker H, Boukef R, Nouira S. Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial. Clin Infect Dis. 2023 Jan 13;76(2):185-191. doi: 10.1093/cid/ciac807. Erratum in: Clin Infect Dis. 2023 Feb 03;: PMID: 36367144.

348
Share this post

VIZIR (Viral Infection treatment with oral ZInc: a Randomized controlled trial in COVID-19)

petermcculloughmd.substack.com
75
Share
75 Comments
Share this discussion

VIZIR (Viral Infection treatment with oral ZInc: a Randomized controlled trial in COVID-19)

petermcculloughmd.substack.com
Eye-of-Agamotto
Apr 10

FWIW, I've been supplementing with 50 mg of chelated zinc for nearly 30 years, as well as making my own liposomal vitamin C. My daily supplementation has been chelated zinc 50 mg, 1000 mg lipsomal Vit C, 5000 IU Vit D, and 100 mg of powdered reishi & chaga mushroom. I have the nickname "Ironman" at work because when everyone else gets sick, I don't.

Granted, I did come down with covid in Jan 2022 and it had the whole dept buzzing as it was the first time in 20 years that I had called in sick. I took a single dose of Ivermectin and was my normal self within 2 days. With that exception, I haven't gotten sick once since 1997 when I started it. And I work in a environment where there is a huge amount of contact with the public where there are more sick days allotted to employees for that very reason.

And I *never* got a flu shot.

Expand full comment
Reply
Share
11 replies
Kelli
Apr 10

Dr Zelenko knew this and published the info in mid 2020.

Expand full comment
Reply
Share
3 replies
73 more comments...
Top
New
Community

No posts

Ready for more?

© 2023 Peter McCullough MD MPH
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing